These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 18601990
1. In vitro inhibitory activities of plants used in Lebanon traditional medicine against angiotensin converting enzyme (ACE) and digestive enzymes related to diabetes. Loizzo MR, Saab AM, Tundis R, Menichini F, Bonesi M, Piccolo V, Statti GA, de Cindio B, Houghton PJ, Menichini F. J Ethnopharmacol; 2008 Sep 02; 119(1):109-16. PubMed ID: 18601990 [Abstract] [Full Text] [Related]
2. Inhibitory activity of α-amylase and α-glucosidase by plant extracts from the Brazilian cerrado. Souza PM, Sales PM, Simeoni LA, Silva EC, Silveira D, Magalhães Pde O. Planta Med; 2012 Mar 02; 78(4):393-9. PubMed ID: 22134849 [Abstract] [Full Text] [Related]
3. Phenolic-rich extracts from selected tropical underutilized legumes inhibit α-amylase, α-glucosidase, and angiotensin I converting enzyme in vitro. Ademiluyi AO, Oboh G. J Basic Clin Physiol Pharmacol; 2012 Jan 19; 23(1):17-25. PubMed ID: 22865445 [Abstract] [Full Text] [Related]
4. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean. McCue P, Kwon YI, Shetty K. Asia Pac J Clin Nutr; 2005 Jan 19; 14(2):145-52. PubMed ID: 15927931 [Abstract] [Full Text] [Related]
5. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes. Deo P, Hewawasam E, Karakoulakis A, Claudie DJ, Nelson R, Simpson BS, Smith NM, Semple SJ. BMC Complement Altern Med; 2016 Nov 04; 16(1):435. PubMed ID: 27809834 [Abstract] [Full Text] [Related]
6. Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro. Ademiluyi AO, Oboh G. Exp Toxicol Pathol; 2013 Mar 04; 65(3):305-9. PubMed ID: 22005499 [Abstract] [Full Text] [Related]
7. In vitro inhibitory potential of selected Malaysian plants against key enzymes involved in hyperglycemia and hypertension. Loh SP, Hadira O. Malays J Nutr; 2011 Apr 04; 17(1):77-86. PubMed ID: 22135867 [Abstract] [Full Text] [Related]
8. In vitro studies of Gynura divaricata (L.) DC extracts as inhibitors of key enzymes relevant for type 2 diabetes and hypertension. Wu T, Zhou X, Deng Y, Jing Q, Li M, Yuan L. J Ethnopharmacol; 2011 Jun 22; 136(2):305-8. PubMed ID: 21570455 [Abstract] [Full Text] [Related]
9. Screening of selected Arabian medicinal plant extracts for inhibitory activity against peptidases. Oleski A, Lindequist U, Mothana RA, Melzig MF. Pharmazie; 2006 Apr 22; 61(4):359-61. PubMed ID: 16649556 [Abstract] [Full Text] [Related]
13. Cytotoxic activity of Brazilian Cerrado plants used in traditional medicine against cancer cell lines. de Mesquita ML, de Paula JE, Pessoa C, de Moraes MO, Costa-Lotufo LV, Grougnet R, Michel S, Tillequin F, Espindola LS. J Ethnopharmacol; 2009 Jun 25; 123(3):439-45. PubMed ID: 19501276 [Abstract] [Full Text] [Related]
18. Effect of Ficus racemosa stem bark on the activities of carbohydrate hydrolyzing enzymes: an in vitro study. Ahmed F, Urooj A. Pharm Biol; 2010 May 25; 48(5):518-23. PubMed ID: 20645793 [Abstract] [Full Text] [Related]
19. Studies on the potential antioxidant properties of Senecio stabianus Lacaita (Asteraceae) and its inhibitory activity against carbohydrate-hydrolysing enzymes. Tundis R, Menichini F, Loizzo MR, Bonesi M, Solimene U, Menichini F. Nat Prod Res; 2012 May 25; 26(5):393-404. PubMed ID: 21644170 [Abstract] [Full Text] [Related]